OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Webinar on Cancer Biomarker
Cancer Biomarker Webinar

OriGene TissueScan in recent publications
Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis J. Natl. Cancer Inst. Apr 2015 [Tissues]

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

Comparison of custom capture for targeted next-generation DNA sequencing J Mol Diagn Jan 2015 []

RNA (5 µg); Colon: right; Within normal limits

Specifications Related Products Research Agreement FAQs
Catalog No. Description Price Shipping
CR560836 RNA (5 µg); Colon: right; Within normal limits $ 289 3 days
<< Back to Search Result   Add to Shopping Cart
Disease StateNormal
Diagnosis CategoryNormal
TissueColon
Case IDCI0000005468
Prep4
Vial IDRN00001519
Frozen Sample IDFR5B336FC9
Tissue of OriginColon: right
Site of FindingColon: right
AppearanceNormal
Sample Diagnosis (from Pathology Verification)Within normal limits
Normal100%
Lesional0%
Tumor0%
Tumor Hypo/Acellular Stroma0%
Tumor Hypercellular Stroma0%
Necrosis0%
Pathology Verification notes from H&E review70% mucosa, 30% submucosa
Bioanalyzer Ratio (28S/18S)1.47
CASE Diagnosis (from medical center path report)Adenocarcinoma of colon
Age89
GenderFemale
RaceWhite or Caucasian
Tumor GradeNot applicable
Minimum Stage GroupingNot applicable
T (Extent of Primary Tumor)Not applicable
N (Lymph node metastasis)Not applicable
M (Distant metastasis)Not applicable
Diagnostic Test Results

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title